LEADER 01302oam  2200409Ia 450 
001 9910698938803321
005 20090825121639.0
035   $a(CKB)5470000002398489
035   $a(OCoLC)424512118
035   $a(EXLCZ)995470000002398489
100   $a20090713d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eimpurities, residual solvents in new veterinary medicinal products, active substances and excipients
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Veterinary Medicine,$d[2001]
215   $a1 online resource (20 pages)
300   $a"VICH GL 18".
300   $a"Final guidance".
300   $a"May 15, 2001".
517   $aGuidance for industry 
606   $aDrug adulteration
606   $aSolvents
606   $aVeterinary drugs
615  0$aDrug adulteration.
615  0$aSolvents.
615  0$aVeterinary drugs.
712 02$aCenter for Veterinary Medicine (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698938803321
996   $aGuidance for industry$93434577
997   $aUNINA